Menu

ARS Pharmaceuticals, Inc. SPRY

Full chart Compare
Set alert

Price alert · SPRY

All alert types
2.79 USD +0.14 (+5.28%)

At closeNov 6, 2026, 6:40 PM EST

2.78 -0.01 -0.36%

After hours · Nov 6, 6:40 PM ET

2.44 Day range 2.84
2.65 52-week range 13.06
YTD
-76.05%
1 year
-65.93%

Revenue & Expenses

Revenue by
Other Income → Expenses: $8.07MIncome Tax Benefit → Expenses: $80.00KExpenses → Selling, General & Admin: $230.12MExpenses → Research & Development: $13.18MUnited States → Revenue: $72.19MGross Profit → Expenses: $63.85MRevenue → Gross Profit: $63.85MRevenue → Cost of Revenue: $20.42MNon-US → Revenue: $12.09MNet Loss → Expenses: $171.30MOther Income$8.07MIncome Tax Benefit$80.00KGross Profit$63.85MNet Loss$171.30MCost of Revenue$20.42MExpenses$243.30MSelling, General & Admin$230.12MResearch & Development$13.18MRevenue$84.28MUnited States$72.19MNon-US$12.09M

Latest period ending Dec 31, 2025 · select a line to chart its full history

Annual income statement

SPRY annual income statement
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
84.28M89.15M30.00K1.32M5.51M
84.28M89.15M30.00K1.32M5.51M
20.42M977.00K000
63.85M88.17M30.00K1.32M5.51M
243.30M91.25M67.55M36.83M24.96M
13.18M19.58M20.27M18.38M20.27M
230.12M71.67M47.28M18.46M4.69M
-179.45M-3.08M-67.52M-35.52M-19.45M
2.60M0000
-80.00K288.00K000
-171.30M8.00M-54.37M-34.68M-20.24M
-171.30M8.00M-54.37M-34.68M-20.24M
-171.30M8.00M-54.37M-34.68M-20.24M
-171.30M8.00M-54.37M-34.68M-20.24M
-1.740.08-0.57-0.87-0.70
-1.740.08-0.57-0.87-0.70
-1.740.08-0.57-0.87-0.70
-168.78M8.29M-54.37M-34.68M-20.24M
-168.78M8.29M-54.37M-34.68M-20.24M
98.57M96.94M95.22M39.96M28.87M
98.57M102.39M95.22M39.96M28.87M